Acute Drug | Chronic Pretreatment | Ki | KiH/KiLRatio | |
---|---|---|---|---|
−GppNHp/NaCl (High) | +GppNHp/NaCl (Low) | |||
nM | ||||
Naloxone | None | 67.1 ± 4.9 | 12.4 ± 0.97** | 5.5 ± 0.25 |
Morphine | 69.2 ± 2.7 | 11.3 ± 2.4** | 6.5 ± 1.0 | |
DPDPE | 61.6 ± 5.3 | 5.3 ± 1.4** | 13.4 ± 3.52-a | |
Naltriben | None | 0.23 ± 0.04 | 0.15 ± 0.03 | 1.6 ± 0.09 |
Morphine | 0.19 ± 0.02 | 0.11 ± 0.03 | 1.9 ± 0.3 | |
DPDPE | 0.22 ± 0.07 | 0.036 ± 0.012-150 | 8.2 ± 2.2b |
The displacement of [3H]diprenorphine binding by nalxone or naltriben to membranes prepared from opioid naı̈ve, and morphine- or DPDPE-pretreated GH3DORT8 cells was determined. Cells were treated with or without 20 μM morphine or 1 μM DPDPE for 48 h. Membranes were prepared from extensively washed cells as described under Materials and Methods. Competition binding was determined with 1 nM [3H]diprenorphine and increasing concentrations of naloxone or naltriben in the presence or absence of 25 μM GppNHp and 100 mM NaCl. Affinity (Ki) values are expressed as mean ± S.E.M and were calculated from IC50 values derived from complete concentration-effect curves. The Kd values for [3H]diprenorphine in GH3DORT8 membranes used to calculate the presentedKi values were obtained from Martin et al. (2002) and are 0.71 ± 0.04 nM (−GppNHp/NaCl) and 1.06 ± 0.14 nM (+GppNHp/NaCl). Results are presented as the mean ± S.E.M. from three to six experiments performed in triplicate.